|
|||||
|
|
Allergen‐specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy |
|
| Authors: | M. Bonvalet H. Moussu E. Wambre C. Ricarte S. Horiot A.‐C. Rimaniol W. W. Kwok F. Horak O. de Beaumont V. Baron‐Bodo P. Moingeon |
| Affiliation: | 1. Stallergenes, , Antony, France;2. Benaroya Research Institute, , Seattle, WA, USA;3. Bertin Pharma, , Montigny le Bretonneux, France;4. Department Vienna Challenge Chamber, Allergy Center Vienna West, , Vienna, Austria |
| Abstract: | |
| Keywords: | allergen biomarker CD4+ T lymphocyte grass pollen MHC class II tetramers sublingual immunotherapy |